“…Besides these they are endowed with anticonvulsant [6], cardio tonic [7] and vasorelaxant activities [8] and also comply as anti-inflammatory, analgesic, antihypoxic and antipyretic agents [9]. Numerous protocols have been developed for the synthesis of 3,4-dihydro-1H-indazolo [1,2-b]phthalazine-1,6,11(2H,13H)-triones using p-TSA [10], ionic liquids [11], (S)-CSA [12], dodecylphosphonic acid (DPA) [13], heteropoly acids [14], Ce(SO 4 ) 2 Á4H 2 O [15], solid acids [16], montmorillonite K-10 [17], N-halosulfonamides [11], silicasulfuric acid [18], phosphomolybdic acid-silica (PMA-SiO 2 ) [19] as catalysts. However, some of the synthetic strategies suffer from certain limitations such as expensive catalysts, low yields of products, long reaction times, use of toxic solvents, tedious procedures for preparation of catalysts and tedious work-up conditions.…”